A detailed history of Wealth Management Partners, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Wealth Management Partners, LLC holds 10,500 shares of IBRX stock, worth $21,840. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,500
Previous 16,000 34.38%
Holding current value
$21,840
Previous $42,000 40.48%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 21, 2025

SELL
$2.24 - $3.01 $12,320 - $16,555
-5,500 Reduced 34.38%
10,500 $25,000
Q2 2025

Jul 11, 2025

BUY
$1.89 - $3.44 $30,240 - $55,040
16,000 New
16,000 $42,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $833M
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Wealth Management Partners, LLC Portfolio

Follow Wealth Management Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Management Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Management Partners, LLC with notifications on news.